GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Gencurix Inc (XKRX:229000) » Definitions » Beneish M-Score

Gencurix (XKRX:229000) Beneish M-Score : -4.18 (As of May. 27, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Gencurix Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -4.18 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Gencurix's Beneish M-Score or its related term are showing as below:

XKRX:229000' s Beneish M-Score Range Over the Past 10 Years
Min: -6.37   Med: -4.04   Max: 5.37
Current: -4.18

During the past 7 years, the highest Beneish M-Score of Gencurix was 5.37. The lowest was -6.37. And the median was -4.04.


Gencurix Beneish M-Score Historical Data

The historical data trend for Gencurix's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gencurix Beneish M-Score Chart

Gencurix Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - - -4.99 -6.37 -3.44

Gencurix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.11 -4.81 -4.91 -3.44 -4.18

Competitive Comparison of Gencurix's Beneish M-Score

For the Diagnostics & Research subindustry, Gencurix's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gencurix's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Gencurix's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Gencurix's Beneish M-Score falls into.



Gencurix Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Gencurix for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0+0.528 * 0.8494+0.404 * 1.6064+0.892 * 1.3097+0.115 * 0.0743
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.5659+4.679 * -0.254379-0.327 * 0.4715
=-4.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was ₩0 Mil.
Revenue was 815.961 + 577.758 + 957.743 + 545.622 = ₩2,897 Mil.
Gross Profit was 568.162 + 192.061 + 636.532 + 269.991 = ₩1,667 Mil.
Total Current Assets was ₩11,131 Mil.
Total Assets was ₩33,124 Mil.
Property, Plant and Equipment(Net PPE) was ₩0 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩1,030 Mil.
Selling, General, & Admin. Expense(SGA) was ₩5,419 Mil.
Total Current Liabilities was ₩15,072 Mil.
Long-Term Debt & Capital Lease Obligation was ₩0 Mil.
Net Income was -3233.537 + -3393.54 + -3565.756 + -6164.52 = ₩-16,357 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₩0 Mil.
Cash Flow from Operations was 0 + -2535.796 + -2573.919 + -2821.668 = ₩-7,931 Mil.
Total Receivables was ₩1,280 Mil.
Revenue was 519.195 + 677.352 + 480.298 + 535.203 = ₩2,212 Mil.
Gross Profit was 249.655 + 265.634 + 256.831 + 308.869 = ₩1,081 Mil.
Total Current Assets was ₩4,378 Mil.
Total Assets was ₩31,129 Mil.
Property, Plant and Equipment(Net PPE) was ₩13,885 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩1,115 Mil.
Selling, General, & Admin. Expense(SGA) was ₩2,642 Mil.
Total Current Liabilities was ₩26,103 Mil.
Long-Term Debt & Capital Lease Obligation was ₩3,939 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0 / 2897.084) / (1279.649 / 2212.048)
=0 / 0.578491
=0

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1080.989 / 2212.048) / (1666.746 / 2897.084)
=0.488682 / 0.575318
=0.8494

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (11130.685 + 0) / 33123.739) / (1 - (4377.759 + 13884.827) / 31129.204)
=0.663967 / 0.413329
=1.6064

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2897.084 / 2212.048
=1.3097

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1115.223 / (1115.223 + 13884.827)) / (1029.922 / (1029.922 + 0))
=0.074348 / 1
=0.0743

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(5419.203 / 2897.084) / (2642.457 / 2212.048)
=1.870572 / 1.194575
=1.5659

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 15072.376) / 33123.739) / ((3938.697 + 26102.694) / 31129.204)
=0.455032 / 0.965055
=0.4715

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-16357.353 - 0 - -7931.383) / 33123.739
=-0.254379

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Gencurix has a M-score of -4.18 suggests that the company is unlikely to be a manipulator.


Gencurix Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Gencurix's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Gencurix (XKRX:229000) Business Description

Traded in Other Exchanges
N/A
Address
9th Floor, Hanhwa Bizmetro I, Guro 3-dong, Guro-gu, Seoul, KOR, 152-733
Gencurix Inc develops diagnosis treatment kits. It offers products including GenesWell BCT, a breast cancer test; GenesWell ddEGFR Mutation Test; GenesWell CDx EGFR Mutation Test; and GenesWell ddEGFR mutation Test.

Gencurix (XKRX:229000) Headlines

No Headlines